The present invention relates to optionally substituted 1-oxa-3,8-diaza-spiro[4.5]decan-2-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease condition associated with a monoamine receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.

 
Web www.patentalert.com

< Method to inhibit ischemia and reperfusion injury

> Antibodies that immunospecifically bind to B lymphocyte stimulator protein

> Compositions and methods for inhibiting expression of the PCSK9 gene

~ 00508